JP2011503075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011503075A5 JP2011503075A5 JP2010533139A JP2010533139A JP2011503075A5 JP 2011503075 A5 JP2011503075 A5 JP 2011503075A5 JP 2010533139 A JP2010533139 A JP 2010533139A JP 2010533139 A JP2010533139 A JP 2010533139A JP 2011503075 A5 JP2011503075 A5 JP 2011503075A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antidiarrheal
- composition according
- hydrogen
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C[C@@](CCC[C@@](*)(*1)C1C[C@](*C(C[C@@](C(C)(C)C([C@]1C)=O)O)=O)C(C)=Cc2c[s]c(C)n2)C1O Chemical compound C[C@@](CCC[C@@](*)(*1)C1C[C@](*C(C[C@@](C(C)(C)C([C@]1C)=O)O)=O)C(C)=Cc2c[s]c(C)n2)C1O 0.000 description 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98663507P | 2007-11-09 | 2007-11-09 | |
| PCT/US2008/079936 WO2009061587A1 (en) | 2007-11-09 | 2008-10-15 | Corticosteroids to treat epothilone or epothilone derivative induced diarrhea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011503075A JP2011503075A (ja) | 2011-01-27 |
| JP2011503075A5 true JP2011503075A5 (enExample) | 2011-12-01 |
Family
ID=40087318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010533139A Pending JP2011503075A (ja) | 2007-11-09 | 2008-10-15 | エポチロンまたはエポチロン誘導体誘発下痢を処置するためのコルチコステロイド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100267682A1 (enExample) |
| EP (1) | EP2222286A1 (enExample) |
| JP (1) | JP2011503075A (enExample) |
| KR (1) | KR20100096077A (enExample) |
| CN (1) | CN101848708B (enExample) |
| AU (1) | AU2008325016A1 (enExample) |
| BR (1) | BRPI0820338A2 (enExample) |
| CA (1) | CA2703792A1 (enExample) |
| MX (1) | MX2010005119A (enExample) |
| RU (1) | RU2010123028A (enExample) |
| WO (1) | WO2009061587A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY180834A (en) | 2012-09-26 | 2020-12-10 | Aragon Pharmaceuticals Inc | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer |
| JOP20200097A1 (ar) * | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
| EP3519592B1 (en) * | 2016-09-27 | 2022-03-09 | Mayo Foundation for Medical Education and Research | Materials and methods for evaluating cancer |
| MX2020003845A (es) | 2017-10-16 | 2020-11-06 | Aragon Pharmaceuticals Inc | Antiandrógenos para el tratamiento de cáncer de próstata no metastásico resistente a la castración. |
| US10705435B2 (en) | 2018-01-12 | 2020-07-07 | Globalfoundries Inc. | Self-referencing and self-calibrating interference pattern overlay measurement |
| US11686576B2 (en) | 2020-06-04 | 2023-06-27 | Kla Corporation | Metrology target for one-dimensional measurement of periodic misregistration |
| US11796925B2 (en) | 2022-01-03 | 2023-10-24 | Kla Corporation | Scanning overlay metrology using overlay targets having multiple spatial frequencies |
| US12032300B2 (en) | 2022-02-14 | 2024-07-09 | Kla Corporation | Imaging overlay with mutually coherent oblique illumination |
| US12422363B2 (en) | 2022-03-30 | 2025-09-23 | Kla Corporation | Scanning scatterometry overlay metrology |
| US12487190B2 (en) | 2022-03-30 | 2025-12-02 | Kla Corporation | System and method for isolation of specific fourier pupil frequency in overlay metrology |
| US12235588B2 (en) | 2023-02-16 | 2025-02-25 | Kla Corporation | Scanning overlay metrology with high signal to noise ratio |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1231894A (zh) * | 1998-04-14 | 1999-10-20 | 陈水清 | 止泻栓 |
| SI1372650T1 (sl) * | 2001-03-19 | 2009-04-30 | Novartis Ag | Kombinacije, ki obsegajo antidiaroično sredstvo in epotilon ali epotilonski derivat |
| US6974818B2 (en) * | 2002-03-01 | 2005-12-13 | Euro-Celtique S.A. | 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain |
| WO2004032923A1 (en) * | 2002-10-11 | 2004-04-22 | Dana-Farber Cancer Institute Inc | Epothilone derivatives for the treatment of multiple myeloma |
| TW200616626A (en) * | 2004-07-26 | 2006-06-01 | Novartis Ag | Epothilone combinations |
-
2008
- 2008-10-15 JP JP2010533139A patent/JP2011503075A/ja active Pending
- 2008-10-15 AU AU2008325016A patent/AU2008325016A1/en not_active Abandoned
- 2008-10-15 EP EP08848076A patent/EP2222286A1/en not_active Withdrawn
- 2008-10-15 CN CN2008801149548A patent/CN101848708B/zh not_active Expired - Fee Related
- 2008-10-15 CA CA2703792A patent/CA2703792A1/en not_active Abandoned
- 2008-10-15 MX MX2010005119A patent/MX2010005119A/es not_active Application Discontinuation
- 2008-10-15 BR BRPI0820338A patent/BRPI0820338A2/pt not_active IP Right Cessation
- 2008-10-15 US US12/741,680 patent/US20100267682A1/en not_active Abandoned
- 2008-10-15 WO PCT/US2008/079936 patent/WO2009061587A1/en not_active Ceased
- 2008-10-15 RU RU2010123028/15A patent/RU2010123028A/ru not_active Application Discontinuation
- 2008-10-15 KR KR1020107010102A patent/KR20100096077A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011503075A5 (enExample) | ||
| JP6740497B2 (ja) | 癌を治療するための方法及び組成物 | |
| JP3441459B2 (ja) | ホルモン補充のための薬剤の調整方法 | |
| DE69928104T2 (de) | Medizinische anwendung eines selektiven estrogenrezeptormodulators in kombination mit einer sexualsteroid-vorstufe | |
| US5763433A (en) | Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof | |
| TWI362932B (en) | Pharmaceutical composition for transdermal delivery and uses thereof | |
| JP2010506867A (ja) | 女性の性欲を維持、及び／又は亢進するための経口治療のための、吉草酸エストラジオール又は１７β−エストラジオールとジエノゲストとの組み合わせの使用 | |
| KR20050057086A (ko) | 치료적 처치 방법 | |
| CN101848708B (zh) | 皮质类固醇用于制备治疗埃坡霉素或埃坡霉素衍生物诱导的腹泻的药物 | |
| JP2011116771A (ja) | 電気痙攣療法（「ｅｃｔ」）に対する治療応答を増大させるための方法 | |
| WO1998025632A1 (en) | Compositions and methods for enhancement of dehydroepiandrosterone | |
| Reus et al. | Antiglucocorticoid treatments in psychiatry | |
| US20120245552A1 (en) | Combination Therapy | |
| TW200529861A (en) | Methods and reagents for the treatment of inflammatory disorders | |
| TW200422042A (en) | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines | |
| WO1997032588A2 (de) | Kombination von dehydroepiandrosteron und aromatasehemmern und verwendung dieser kombination zur herstellung eines arzneimittels zur behandlung eines relativen und absoluten androgenmangels beim mann | |
| KR20100121601A (ko) | 면역염증성 질환의 치료를 위한 치료요법 | |
| Cagnacci et al. | The effect of hormonal contraceptives on metabolism | |
| WO2002074315A1 (de) | Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie | |
| CN1582153A (zh) | (11β,17β)－11－( 1,3－苯并间二氧杂环戊烯－5－基)－17－羟基－17－(1－丙炔基)雌－4,9－二烯－3－酮在治疗重性抑郁症中的应用 | |
| JP2014508809A (ja) | アンドロゲンを用いたミエリン再生 | |
| EP0966289B1 (de) | Budesonid zur behandlung von cholestatischen lebererkrankungen | |
| WO2007042110A1 (de) | Verfahren zur herstellung eines einphasigen pharmazeutischen präparates zur oralen therapie der dysfunktionellen uterinen blutung | |
| DE10134768A1 (de) | Pharmazeutische Kombinationspräparate enthaltend Aromatasehemmer und Substanzen mit estrogener Wirkung sowie ihre Verwendung | |
| DE102009044375A1 (de) | Verwendung von Inhibitoren der Aldosteron-Synthase zur Behandlung von Hyperaldosteronismus und Herz-Kreislauf-Erkrankungen |